We consider some concurrent diseases that might up-regulate VEGF (e.g., tumours, ischemia, trauma and inflammation), differences in technologies used, sample sizes and populations included would explain variations in CSF and serum levels of VEGF55. Here, VEGFA is linked to neoplasm.